Figure 5.

Blood concentrations of ATB key active components after intraperitoneal administration of 500 mg/kg once a day in seven days and saliva concentration at day seventh (n = 5).

Blood concentrations of ATB key active components after intraperitoneal administration of 500 mg/kg once a day in seven days and saliva concentration at day seventh (n = 5).